Nucala is an injectable biologic medication approved for the treatment of nasal polyps and eosinophilic asthma. It works by targeting a specific immune pathway involved in chronic inflammation, helping to reduce polyp size, prevent regrowth, and improve overall sinus health.
Administered as a monthly injection, Nucala is typically used in patients who have failed other treatments or who experience frequent sinus surgery recurrences. Dr. Kumra collaborates with allergists and pulmonologists to determine if Nucala is appropriate and to ensure coordinated, whole-patient care.
For individuals living with nasal polyps, asthma, and chronic congestion, Nucala offers a long-term solution with real, measurable relief.
